This project is intended for HCPs and has been funded by Bayer and fully created by EMJ.
This video podcast covers the current treatment landscape for mHSPC and covers the burden of comorbidities and polypharmacy. Our experts then dive deeper into several case based scenarios which are seen in practice and provide the clinical expertise on what to consider and how to best manage these hypothetical patient cases.
Speakers
Daniel George1
Alicia Morgans2
Christian Gratzke3
1. Department of Medicine, Duke University School of Medicine, Durham, North Carolina, US.
2. Harvard Medical School, Boston, Massachusetts, US.
3. Department of Urology, Center for Surgery at the Medical Center – University of Freiburg, Germany.
Moderator
Jessica Jinks4
4. EMJ, UK
